13D/13G Filings - Atlas Venture Fund XI L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
4:32 pm
Sale
2024-09-3013GDyne Therapeutics, Inc.
DYN
Atlas Venture Fund XI L.P.5,714,057
5.700%
-1,628,026decrease
(-22.17%)
Filing
History
2024-11-14
4:30 pm
Sale
2024-09-3013GXilio Therapeutics, Inc.
XLO
Atlas Venture Fund XI L.P.0
0.000%
-2,023,402decrease
(Position Closed)
Filing
History
2024-11-14
4:30 pm
Sale
2024-09-3013GDay One Biopharmaceuticals, Inc.
DAWN
Atlas Venture Fund XI L.P.4,869,681
5.500%
-1,178,137decrease
(-19.48%)
Filing
History
2024-11-05
6:26 pm
Sale
2024-11-0113DThird Harmonic Bio, Inc.
THRD
Atlas Venture Fund XI L.P.9,808,190
23.900%
-505,573decrease
(-4.90%)
Filing
History
2024-02-09
4:09 pm
Purchase
2023-12-3113GDyne Therapeutics, Inc.
DYN
Atlas Venture Fund XI L.P.7,342,083
9.100%
15,966increase
(+0.22%)
Filing
History
2024-02-09
4:08 pm
Purchase
2023-12-3113GDay One Biopharmaceuticals, Inc.
DAWN
Atlas Venture Fund XI L.P.6,047,818
6.900%
39,284increase
(+0.65%)
Filing
History
2023-11-13
4:15 pm
Purchase
2023-11-0313DKorro Bio, Inc.
KRRO
Atlas Venture Fund XI L.P.942,075
11.800%
942,075increase
(New Position)
Filing
History
2023-02-14
4:31 pm
Sale
2022-12-3113GAkero Therapeutics, Inc.
AKRO
Atlas Venture Fund XI L.P.467,529
1.000%
-1,496,000decrease
(-76.19%)
Filing
History
2023-02-14
4:29 pm
Unchanged
2022-12-3113GDyne Therapeutics, Inc.
DYN
Atlas Venture Fund XI L.P.7,326,117
14.100%
0
(Unchanged)
Filing
History
2023-02-14
4:23 pm
Sale
2022-12-3113GDay One Biopharmaceuticals, Inc.
DAWN
Atlas Venture Fund XI L.P.6,008,534
8.200%
-1,201,708decrease
(-16.67%)
Filing
History
2022-09-29
4:30 pm
Purchase
2022-09-1913DThird Harmonic Bio, Inc.
THRD
Atlas Venture Fund XI L.P.10,313,763
25.600%
10,313,763increase
(New Position)
Filing
History
2022-02-11
5:04 pm
Sale
2021-12-3113GDyne Therapeutics, Inc.
DYN
Atlas Venture Fund XI L.P.7,326,117
14.200%
-814,013decrease
(-10.00%)
Filing
History
2022-02-11
5:03 pm
Sale
2021-12-3113GAkero Therapeutics, Inc.
AKRO
Atlas Venture Fund XI L.P.1,963,529
5.600%
-242,883decrease
(-11.01%)
Filing
History
2022-02-11
5:03 pm
Purchase
2021-06-0113GDay One Biopharmaceuticals, Inc.
DAWN
Atlas Venture Fund XI L.P.7,210,242
11.600%
7,210,242increase
(New Position)
Filing
History
2021-11-05
4:43 pm
Purchase
2021-10-2613GXilio Therapeutics, Inc.
XLO
Atlas Venture Fund XI L.P.2,023,402
7.600%
2,023,402increase
(New Position)
Filing
History
2021-02-16
5:28 pm
Purchase
2020-12-3113GDyne Therapeutics, Inc.
DYN
Atlas Venture Fund XI L.P.8,140,130
17.900%
8,140,130increase
(New Position)
Filing
History
2021-02-16
5:27 pm
Sale
2020-12-3113GAkero Therapeutics, Inc.
AKRO
Atlas Venture Fund XI L.P.2,206,412
6.400%
-500,000decrease
(-18.47%)
Filing
History
2020-02-13
5:00 pm
Purchase
2019-12-3113GAkero Therapeutics, Inc.
AKRO
Atlas Venture Fund XI L.P.2,706,412
9.500%
2,706,412increase
(New Position)
Filing
History